All In Biotech

Free tool

FAERS Monitor: Firmagon

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022201 or its brand name (Firmagon, Degarelix Acetate). Reports on generic versions are filed under their own applications.

Reports

5,333

Serious

3,533

66% of reports

Hospitalization

1,733

Death reported

659

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue412
  • injection site pain367
  • hot flush329
  • injection site erythema293
  • death227
  • asthenia224
  • injection site swelling212
  • product storage error209
  • disease progression174
  • pyrexia171
  • prostatic specific antigen increased166
  • fall162
  • dizziness154
  • pain147
  • nausea146

Reports by year received

View as table
YearReports
20072
200934
201079
2011112
2012104
2013140
2014243
2015194
2016332
2017353
2018367
2019350
2020297
2021406
2022479
2023449
2024489
2025571
2026332

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,826 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
prostatic specific antigen increasedSignal16648.141.47,520
hot flushSignal32917.315.65,028
injection site swellingSignal21210.99.61,906
product storage errorSignal2099.48.31,571
injection site erythemaSignal2939.38.42,180
disease progressionSignal1745.85.0690
injection site painSignal3674.74.31,088
astheniaSignal2242.42.1175
fatigueSignal4122.11.9241
pyrexia1711.91.779
fall1621.91.672
dizziness1541.21.06
death2271.00.90
pain1470.90.80
nausea1460.70.615

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.